We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
226
T. Rowe Price
TROW
$25.6B
$3.64M 0.11%
48,313
+29,955
+163% +$2.12M
VUG icon
227
Vanguard Morningstar Growth ETF
VUG
$218B
$3.63M 0.11%
195,588
+7,446
+4% +$138K
OKE icon
228
Oneok
OKE
$56.1B
$3.62M 0.11%
63,101
-22,449
-26% -$1.18M
RDS.A
229
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.62M 0.11%
66,581
-1,361
-2% -$70.1K
HBI
230
DELISTED
Hanesbrands
HBI
$3.62M 0.11%
167,787
+59,259
+55% +$1.42M
BF.B icon
231
Brown-Forman Class B
BF.B
$13.2B
$3.6M 0.1%
125,338
-4,737
-4% -$138K
MU icon
232
Micron Technology
MU
$988B
$3.6M 0.1%
164,312
-5,673
-3% -$107K
EXPE icon
233
Expedia Group
EXPE
$35.2B
$3.58M 0.1%
31,601
+20,189
+177% +$2.46M
CL icon
234
Colgate-Palmolive
CL
$73.3B
$3.58M 0.1%
54,640
-546
-1% -$37.4K
VOD icon
235
Vodafone
VOD
$37.2B
$3.58M 0.1%
146,346
+19,953
+16% +$525K
PSX icon
236
Phillips 66
PSX
$84.4B
$3.54M 0.1%
40,958
-3,376
-8% -$281K
OLED icon
237
Universal Display
OLED
$3.76B
$3.54M 0.1%
62,865
+2,199
+4% +$121K
PQ
238
DELISTED
Petroquest Energy Inc Wd
PQ
$3.52M 0.1%
1,064,025
+295,000
+38% +$1.1M
PYPL icon
239
PayPal
PYPL
$49.3B
$3.52M 0.1%
89,145
-22,926
-20% -$922K
EPI icon
240
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$3.51M 0.1%
173,767
-15,559
-8% -$323K
HDS
241
DELISTED
HD Supply Holdings, Inc.
HDS
$3.49M 0.1%
82,022
+60,073
+274% +$2.21M
XLV icon
242
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$3.47M 0.1%
50,337
+27,003
+116% +$1.87M
HAL icon
243
Halliburton
HAL
$26.4B
$3.46M 0.1%
63,991
+5,197
+9% +$259K
IAT icon
244
iShares US Regional Banks ETF
IAT
$673M
$3.42M 0.1%
+75,273
New +$3.05M
SPHB icon
245
Invesco S&P 500 High Beta ETF
SPHB
$970M
$3.41M 0.1%
93,214
+73,315
+368% +$2.55M
AEM icon
246
Agnico Eagle Mines
AEM
$76.3B
$3.41M 0.1%
81,118
+32,480
+67% +$1.44M
UNIT
247
Uniti Group
UNIT
$2.26B
$3.38M 0.1%
132,901
+2,813
+2% +$75.8K
QTS
248
DELISTED
QTS REALTY TRUST, INC.
QTS
$3.37M 0.1%
67,900
RRC icon
249
Range Resources
RRC
$9.24B
$3.36M 0.1%
97,859
-1,172
-1% -$41.9K
VGK icon
250
Vanguard FTSE Europe ETF
VGK
$30.8B
$3.35M 0.1%
69,909
-40,947
-37% -$1.93M

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.